Adaptimmune Therapeutics PLC - SPONDS ADR (ADAP)

Q3 2018 13F Holders as of 9/30/2018

Type / Class
Equity / SPONDS ADR
Number of holders
89
Total Shares
65.5M
Shares change
+9.64M
Total reported value, excl. options
$888M
Value change
+$132M
Put/Call ratio
0.23
Number of buys
32
Number of sells
-46
Price
$13.56
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.